This article introduces a research work published in nature structural & molecular biology. The author explores the latest progress and limitations of deep learning methods in predicting the structure of human proteinRead More…
Over the past decade, the Cambridge Healthtech Institute (CHI)’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities andRead More…
Following the accomplishment of the PEGS Summit, 2022 BIO International Convention, and 13th Annual World ADC, this month’s Creative Biolabs event was held this week at the DoubleTree Boston North Shore ConventionRead More…
In the past, components of adaptive immunity were thought to play non-overlapping roles in antimicrobial host defense, with antibodies targeting pathogens in the extracellular environment and T cells responsible for eliminating intracellularRead More…
The study findings, titled “Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination,” were published in Nature by a team of researchers from the University of California, San Francisco, and the affiliated GladstoneRead More…
In a new study, researchers from Emory University revealed that cancer-causing mutations result in widespread distortions in protein-protein interaction networks in cells. The findings were recently published online in the journal Cell.Read More…
Following the PEGS Summit’s accomplishment, Creative Biolabs’ event of the month has launched this Monday at the San Diego Convention Center, and the exhibition at Booth #1754 will last till June 16.Read More…
Cancer has become the second largest health threat in the world, with about 10 million people dying of cancer in 2020. For decades, cytotoxic-based chemotherapy has been the main treatment for allRead More…
Even through relying on the immune system of patients, cancer immunotherapy is still far from fully utilizing the entire body’s natural defense system. In fact, most of these treatments only utilize theRead More…
Multiple myeloma is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, in a recent study published in Science Translational Medicine entitled “Selective targeting of multiple myeloma cellsRead More…